FI86062B - Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyraestrar. - Google Patents

Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyraestrar. Download PDF

Info

Publication number
FI86062B
FI86062B FI892051A FI892051A FI86062B FI 86062 B FI86062 B FI 86062B FI 892051 A FI892051 A FI 892051A FI 892051 A FI892051 A FI 892051A FI 86062 B FI86062 B FI 86062B
Authority
FI
Finland
Prior art keywords
formula
iron
chlorine gas
chloro
per mole
Prior art date
Application number
FI892051A
Other languages
English (en)
Finnish (fi)
Other versions
FI892051A0 (fi
FI86062C (sv
FI892051A (fi
Inventor
Hans Peter Wagner
Original Assignee
Hafslund Nycomed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Pharma filed Critical Hafslund Nycomed Pharma
Publication of FI892051A0 publication Critical patent/FI892051A0/fi
Publication of FI892051A publication Critical patent/FI892051A/fi
Publication of FI86062B publication Critical patent/FI86062B/fi
Application granted granted Critical
Publication of FI86062C publication Critical patent/FI86062C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Claims (4)

1. Förfarande för framställnin9 av 5-klor-3-klorsulfonyl-2-tiofenkarboxy1syraester med formeln (I) 5 SO?Cl ,_V il {I)
10 JL JK C00R där
15 R är C1-c4 alkyl, kännetecknat därav, att en förening med formeln (II) S02C1 20 --/ ΓΊί ^ s COOK 25 där R avser det samma som ovan, kloreras i närvaro av aktiverat järn i ett organiskt 1ösningsmedel, som i reaktionsförhäl- landen är inert, eller i en blandning av sädana lösningsme- del, varvid klorgas mätäs tills 50 - 70 % av den önskade 5-klor-3-klorsulfonyl-2-tiofenkarboxylsyraestern med ; formeln I bildats, varvid nämnda aktiverade järn fram- : : ställts genom att suspendera 0,1 - 1,0 mol metalliskt järn : per mol av en förening med formeln II i 0,5 - 5 liter :./35 organiskt 1ösningsmedel, som i aktiveringsförhäl1anden är * inert, eller i en blandning av sädana 1 ösningsmedel och :V: 100 - 500 g klorgas per mol järn mätäs under 1-5 timmar.
« * , 2. Förfarande enligt patentkravet 1, känneteck- 40. a t därav, att det metalliska järnet aktiveras med klorgas i en 1 ösningssuspension, varvid 0,2 - 0,4 mol * metalliskt järn per mol utgängsämne med formeln II akti-veras i 1 - 3 liter mety 1 enklorid eller tetraklorkolväte * · 4 · » · · »IM» 11 86062 eller i deras blandning genom att leda 200 - 300 g klorgas per mol jam in i suspensionen under 2-3 timmar.
3. För f a rand I* enligt patentkravet 1, kanneteck-5 n a t. därav, att järnets aktivering och kloreringen av föreningarna med formeln II utförs i samma 1ösningsmedel eller 1ösningsblandning.
4. Förfarande enligt patentkravet 1, känneteck-10 n a t därav, att kloreringen av föreningar med formeln II genom matning av 5 - 50 g klorgas per timme och mol av en förening med formeln utförs vid 20 - 50°C, tills 50 - 70 % av den önskade 5 — k 1or-3-klorsulfonyl-2-tiofenkarboxy1syra-estern bildats och därefter halls reaktionsblandningen i 15 isvatten. • · *
FI892051A 1988-05-02 1989-04-28 Förfarande för framställning av 5-klor-3-klorsulfonyl-2-tiofenkarboksy lsyraestrar FI86062C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT112388 1988-05-02
AT0112388A AT390060B (de) 1988-05-02 1988-05-02 Verfahren zur herstellung von 5-chlor-3chlorsulfonyl-2-thiophencarbonsaeureestern

Publications (4)

Publication Number Publication Date
FI892051A0 FI892051A0 (fi) 1989-04-28
FI892051A FI892051A (fi) 1989-11-03
FI86062B true FI86062B (fi) 1992-03-31
FI86062C FI86062C (sv) 1992-07-10

Family

ID=3507085

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892051A FI86062C (sv) 1988-05-02 1989-04-28 Förfarande för framställning av 5-klor-3-klorsulfonyl-2-tiofenkarboksy lsyraestrar

Country Status (28)

Country Link
US (1) US5138072A (sv)
EP (1) EP0340472B1 (sv)
JP (1) JP2785132B2 (sv)
KR (1) KR970000685B1 (sv)
CN (1) CN1028101C (sv)
AT (2) AT390060B (sv)
AU (1) AU614058B2 (sv)
CA (1) CA1333177C (sv)
CS (1) CS275851B6 (sv)
CY (1) CY1756A (sv)
DD (1) DD283818A5 (sv)
DE (1) DE58905010D1 (sv)
DK (1) DK172655B1 (sv)
EG (1) EG20136A (sv)
ES (1) ES2058372T3 (sv)
FI (1) FI86062C (sv)
GR (1) GR3008623T3 (sv)
HK (1) HK128193A (sv)
HU (1) HU202518B (sv)
IL (1) IL89902A0 (sv)
MY (1) MY103874A (sv)
NO (1) NO171912C (sv)
NZ (1) NZ228772A (sv)
PH (1) PH27581A (sv)
SA (1) SA89100027B1 (sv)
SU (1) SU1704632A3 (sv)
YU (1) YU48507B (sv)
ZA (1) ZA892791B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4232417A1 (de) * 1992-09-28 1994-03-31 Bayer Ag Substituierte Thienylsulfonylharnstoffe
DE19540737A1 (de) * 1995-11-02 1997-05-07 Bayer Ag Substituierte Sulfonylamino(thio)carbonylverbindungen
CN103356636A (zh) 2004-05-23 2013-10-23 杰勒德·M·豪斯 Theramutein调节剂
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
EP4424838A2 (en) * 2005-11-23 2024-09-04 Gerard M. Housey Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators
CN116693498B (zh) * 2023-05-30 2024-01-30 湖北广济医药科技有限公司 一种利用连续流动反应合成5-氯-3-(氯磺酰基)-2-噻吩羧酸甲酯的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE698778C (de) * 1934-11-11 1941-07-10 I G Farbenindustrie Akt Ges Verfahren zur Herstellung von organischen Monochlor- oder Monobromverbindungen
DE2227439B2 (de) * 1972-06-06 1977-05-05 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Chlorierung oder bromierung phenolischer verbindungen
DE2534689B2 (de) * 1974-09-16 1979-03-01 Basf Ag, 6700 Ludwigshafen 23-Dihydro-3-oxo-thieno-isothiazol-1,1-dioxide
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
FR2564834A1 (fr) * 1984-05-24 1985-11-29 Du Pont Procede de preparation de 3-chlorosulfonylthiophene-2-carboxylate d'alcoyle
FI862513A (fi) * 1985-07-04 1987-01-05 Chemie Linz Ag Nya tieno-1,2-tiazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
DE3785694T2 (de) * 1986-05-13 1993-09-16 Seitetsu Kagaku Co Ltd Thiophenderivate und verfahren zu ihrer herstellung.

Also Published As

Publication number Publication date
HUT49869A (en) 1989-11-28
NO171912C (no) 1993-05-19
HU202518B (en) 1991-03-28
CY1756A (en) 1994-06-03
EP0340472A1 (de) 1989-11-08
NO171912B (no) 1993-02-08
ES2058372T3 (es) 1994-11-01
SA89100027B1 (ar) 2003-04-09
NO891679L (no) 1989-11-03
HK128193A (en) 1993-11-26
EP0340472B1 (de) 1993-07-28
YU48507B (sh) 1998-09-18
CN1028101C (zh) 1995-04-05
CS275851B6 (en) 1992-03-18
NZ228772A (en) 1990-09-26
DK172655B1 (da) 1999-04-12
YU81089A (en) 1990-06-30
SU1704632A3 (ru) 1992-01-07
AT390060B (de) 1990-03-12
EG20136A (en) 1997-07-31
KR890017240A (ko) 1989-12-15
ATE92056T1 (de) 1993-08-15
PH27581A (en) 1993-08-18
FI892051A0 (fi) 1989-04-28
FI86062C (sv) 1992-07-10
CA1333177C (en) 1994-11-22
US5138072A (en) 1992-08-11
ZA892791B (en) 1989-12-27
DD283818A5 (de) 1990-10-24
JPH01313474A (ja) 1989-12-18
CN1037511A (zh) 1989-11-29
NO891679D0 (no) 1989-04-24
IL89902A0 (en) 1989-12-15
JP2785132B2 (ja) 1998-08-13
AU614058B2 (en) 1991-08-15
DK211189A (da) 1989-11-03
DK211189D0 (da) 1989-05-01
ATA112388A (de) 1989-08-15
DE58905010D1 (de) 1993-09-02
KR970000685B1 (ko) 1997-01-18
MY103874A (en) 1993-09-30
GR3008623T3 (sv) 1993-10-29
AU3380189A (en) 1989-11-02
FI892051A (fi) 1989-11-03

Similar Documents

Publication Publication Date Title
US4146643A (en) Increasing vigilance or treating cerebral insufficiency with substituted vincamines
FI86062B (fi) Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofenkarboksylsyraestrar.
EP0343050B1 (fr) Dérivés de phényl-6 pipérazinyl-alkyl-3 1H,3H-pyrimidinedione-2,4, leur préparation et leur application en thérapeutique
EP0078240A2 (de) Lactone
RU2118323C1 (ru) Способ получения производного эрголина
FR2552081A1 (fr) Procede de preparation de prolines substituees
JP2844868B2 (ja) テトロン酸アルキルエステルの製造方法
Szewczyk et al. Stereochemical studies with aminophosphines and related compounds having the 7-phosphanorbornene structure
CN110950836A (zh) 一种苯并二硫杂环戊烯类骨架化合物的制备方法
JPH0115515B2 (sv)
CN117164462B (zh) 一种二芳基甲烷类化合物及其制备方法和应用
JP3171400B2 (ja) ヒドロキシカルボニル誘導体およびその製造方法
US4861917A (en) Process for preparing macrocyclic 2-halogenoketones
Halton et al. Studies in the cycloproparene series: Approaches to octahydrocyclopropa-[l] phenanthrenes
JPS595595B2 (ja) 15−ヒドロキシイミノ−e−ホモエブルナン誘導体の製造方法
CN114133389B (zh) 制备异吲哚啉-1-酮并环及其类似物的方法
US4560787A (en) Process for preparing 10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-one compounds
JP2625850B2 (ja) チオホスゲンの製造方法
Frey et al. Intramolecular Diels‐Alder reactions. 5 [1] Facile synthesis of an octahydrobenzocycloheptenone derivative utilising intramolecular Diels‐Alder reaction
EP0943604B1 (de) Verfahren zur Herstellung von Malonsäuredinitril
JP4701185B2 (ja) カンプトテシン誘導体の製造方法
JPS6016975A (ja) 双環性化合物のn−イミダゾリル誘導体およびそれらの製造法
KR0176327B1 (ko) 7,8-디플루오로-벤즈옥사진 유도체의 제조방법
RU1775400C (ru) Способ получени 3-эндо-галоген-7,7-бис(трифторметил)-1-азатрицикло [2,2,1,0 @ ]-гептанов
Edgemond Progress toward the total synthesis of aplysistatin and an improved synthesis of hexacene

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NYCOMED DANMARK A/S

FG Patent granted

Owner name: NYCOMED DANMARK A/S

MA Patent expired